177 related articles for article (PubMed ID: 19075752)
1. Relaxin and nitric oxide signalling.
Baccari MC; Bani D
Curr Protein Pept Sci; 2008 Dec; 9(6):638-45. PubMed ID: 19075752
[TBL] [Abstract][Full Text] [Related]
2. Site-related Effects of Relaxin in the Gastrointestinal Tract Through Nitric Oxide Signalling: An Updated Report.
Garella R; Squecco R; Baccari MC
Curr Protein Pept Sci; 2017; 18(12):1254-1262. PubMed ID: 28606038
[TBL] [Abstract][Full Text] [Related]
3. Relaxin up-regulates inducible nitric oxide synthase expression and nitric oxide generation in rat coronary endothelial cells.
Failli P; Nistri S; Quattrone S; Mazzetti L; Bigazzi M; Sacchi TB; Bani D
FASEB J; 2002 Feb; 16(2):252-4. PubMed ID: 11744624
[TBL] [Abstract][Full Text] [Related]
4. Relaxin activates the L-arginine-nitric oxide pathway in vascular smooth muscle cells in culture.
Bani D; Failli P; Bello MG; Thiemermann C; Bani Sacchi T; Bigazzi M; Masini E
Hypertension; 1998 Jun; 31(6):1240-7. PubMed ID: 9622136
[TBL] [Abstract][Full Text] [Related]
5. Relaxin potentiates the expression of inducible nitric oxide synthase by endothelial cells from human umbilical vein in in vitro culture.
Quattrone S; Chiappini L; Scapagnini G; Bigazzi B; Bani D
Mol Hum Reprod; 2004 May; 10(5):325-30. PubMed ID: 15026539
[TBL] [Abstract][Full Text] [Related]
6. Relaxin and gastrointestinal motility.
Baccari MC; Squecco R; Garella R
Ital J Anat Embryol; 2013; 118(1 Suppl):80-1. PubMed ID: 24640580
[TBL] [Abstract][Full Text] [Related]
7. Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells.
Bani D; Masini E; Bello MG; Bigazzi M; Sacchi TB
Cancer Res; 1995 Nov; 55(22):5272-5. PubMed ID: 7585587
[TBL] [Abstract][Full Text] [Related]
8. Reversal by relaxin of altered ileal spontaneous contractions in dystrophic (mdx) mice through a nitric oxide-mediated mechanism.
Baccari MC; Nistri S; Vannucchi MG; Calamai F; Bani D
Am J Physiol Regul Integr Comp Physiol; 2007 Aug; 293(2):R662-8. PubMed ID: 17522128
[TBL] [Abstract][Full Text] [Related]
9. Relaxin: new functions for an old peptide.
Baccari MC; Calamai F
Curr Protein Pept Sci; 2004 Feb; 5(1):9-18. PubMed ID: 14965317
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of relaxin in cardiac anaphylaxis: involvement of the nitric oxide pathway.
Masini E; Zagli G; Ndisang JF; Solazzo M; Mannaioni PF; Bani D
Br J Pharmacol; 2002 Oct; 137(3):337-44. PubMed ID: 12237253
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment with Relaxin Does Not Restore NO-Mediated Modulation of Calcium Signal in Coronary Endothelial Cells Isolated from Spontaneously Hypertensive Rats.
Nistri S; Di Cesare Mannelli L; Ghelardini C; Zanardelli M; Bani D; Failli P
Molecules; 2015 May; 20(6):9524-35. PubMed ID: 26016544
[TBL] [Abstract][Full Text] [Related]
12. Relaxin-induced increased coronary flow through stimulation of nitric oxide production.
Bani-Sacchi T; Bigazzi M; Bani D; Mannaioni PF; Masini E
Br J Pharmacol; 1995 Sep; 116(1):1589-94. PubMed ID: 8564223
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of relaxin on human basophils activated by stimulation of the Fc epsilon receptor. The role of nitric oxide.
Bani D; Baronti R; Vannacci A; Bigazzi M; Sacchi TB; Mannaioni PF; Masini E
Int Immunopharmacol; 2002 Jul; 2(8):1195-204. PubMed ID: 12349956
[TBL] [Abstract][Full Text] [Related]
14. Relaxin ameliorates salt-sensitive hypertension and renal fibrosis.
Yoshida T; Kumagai H; Suzuki A; Kobayashi N; Ohkawa S; Odamaki M; Kohsaka T; Yamamoto T; Ikegaya N
Nephrol Dial Transplant; 2012 Jun; 27(6):2190-7. PubMed ID: 22086971
[TBL] [Abstract][Full Text] [Related]
15. Physiological or pathological--a role for relaxin in the cardiovascular system?
Samuel CS; Parry LJ; Summers RJ
Curr Opin Pharmacol; 2003 Apr; 3(2):152-8. PubMed ID: 12681237
[TBL] [Abstract][Full Text] [Related]
16. Relaxin-a pleiotropic hormone and its emerging role for experimental and clinical therapeutics.
Dschietzig T; Bartsch C; Baumann G; Stangl K
Pharmacol Ther; 2006 Oct; 112(1):38-56. PubMed ID: 16647137
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide signalling in cardiovascular health and disease.
Farah C; Michel LYM; Balligand JL
Nat Rev Cardiol; 2018 May; 15(5):292-316. PubMed ID: 29388567
[TBL] [Abstract][Full Text] [Related]
18. Relaxin depresses platelet aggregation: in vitro studies on isolated human and rabbit platelets.
Bani D; Bigazzi M; Masini E; Bani G; Sacchi TB
Lab Invest; 1995 Nov; 73(5):709-16. PubMed ID: 7474945
[TBL] [Abstract][Full Text] [Related]
19. Relaxin inhibits lipopolysaccharide-induced adhesion of neutrophils to coronary endothelial cells by a nitric oxide-mediated mechanism.
Nistri S; Chiappini L; Sassoli C; Bani D
FASEB J; 2003 Nov; 17(14):2109-11. PubMed ID: 14500542
[TBL] [Abstract][Full Text] [Related]
20. Relaxin up-regulates the nitric oxide biosynthetic pathway in the mouse uterus: involvement in the inhibition of myometrial contractility.
Bani D; Baccari MC; Nistri S; Calamai F; Bigazzi M; Sacchi TB
Endocrinology; 1999 Oct; 140(10):4434-41. PubMed ID: 10499496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
